The cyclooxygenase-2 inhibitors are not antiplatelet drugs. [2] In 1998 only one drug in this class was available, a monoclonal antibody (abciximab) directed against the fibrinogen receptor on the ...

Pharmacogenomics may play an important role in antiplatelet drug treatment in patients with CAD with PCI, but no widespread application in clinical practice is observed yet. Prasugrel and ...

DUBLIN--(BUSINESS WIRE)--The "Antiplatelet Market: Analysis By Drug Class, By Route of Administration, By Distribution Channel, By Region Size and Trends" report has been added to ...

Blood thinners are essential medications for managing and preventing serious health conditions, but many people know little ...

Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...

CureGene Pharmaceutical ('CureGene'), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the ...

Women who have had strokes may be more likely than men to skip doses of medications that could help prevent a second stroke, ...

The antiplatelet drug has been recommended for approval by the US regulator's cardiovascular and renal drugs advisory committee, which voted 10-1 in favour. The anticlotting agent would be the ...

The researchers also found that, on the contrary, the use of antiplatelet drugs may be linked to a higher risk of dementia. Antiplatelet drugs are medicines used to prevent strokes and stop ...

For longer term secondary stroke prevention, antiplatelet agents, control of vascular risk factors, and, most importantly, abstinence from cocaine should be the focus of our treatment recommendations.